Refining pathological response assessment in neoadjuvant therapy for melanoma | 40 min
In this presentation, Pathologist Prof Richard Scolyer AO discusses how neoadjuvant therapy is transforming melanoma patient care. He also answers key questions around neoadjuvant-treated melanoma patients, including:
- Does radiology correlate with pathology?
- Is pathological response assessment reproducible?
- What factors are associated with response and prolonged survival?
- How can we move the field forward as neoadjuvant therapy becomes standard of care?
This virtual presentation was recorded for the Christian Blank Oration in October 2022 and is suitable for Pathologists and Oncologists.
Prof Richard Scolyer AO
Co-Medical Director, Melanoma Institute Australia | Pathologist, Melanoma Institute Australia, Senior Staff Specialist, Royal Prince Alfred Hospital
Clinical Professor, The University of Sydney
Declaration of Interest
Fantastic PresentationThanks Dr Scolyer for a fantastic presentation!